Open sidebar
Reports

Vaccine Coverage - Third/Booster Doses

Description
Report on COVID-19 vaccination coverage in England focussing on THIRD/booster doses which are due, based on the booster dose schedule (14 weeks since second dose). Report based on those 16 years of age or older and registered with practices that use TPP SystmOne software. UPDATE: we are no longer updating these reports on a regular basis. If you do rely on these reports and data releases in your own work, please get in touch at the email address below.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: team@opensafely.org
First published
16 Nov 2021
Last released
17 Aug 2022
DOI
http://doi.org/10.53764/rpt.e780b8d9d0
Links

OpenSAFELY COVID Vaccine coverage report: Booster / third doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our most recent weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of 17 March 2021) in our peer-reviewed publication in the British Journal of General Practice.

The full analytical methods behind the latest results in this report are available here.

Update: Our vaccine reports are no longer being updated. If you rely on more regular data updates for your own reporting or analysis please contact team@opensafely.org to let us know.

Booster/Third doses

Report last updated 29 Jun 2022

Third dose vaccinations included up to 22 Jun 2022 inclusive

This report is intended to highlight any differences between subgroups of priority cohorts in receiving 'booster' doses (or third primary doses where eligible), at least 14 weeks after their second dose.

Only persons who had their second dose at least 14 weeks ago (16 Mar 2022) are included in the 'due' group.

Vaccine types

Note: numbers may not sum to 100% as it is not always possible to determine vaccine type given, and patients occasionally have more than one brand recorded on the same day.

Oxford-AZ vaccines (% of all third doses): 0.1% (15,708)

Pfizer vaccines (% of all third doses): 76.3% (10,166,982)

Moderna vaccines (% of all third doses): 23.5% (3,131,184)

Contents

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Back to top

Cumulative third dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,109,941 24,059 1,085,882 97.8 1,156,330
Sex F 636,993 15,484 621,509 97.6 664,657
M 472,948 8,582 464,366 98.2 491,673
Age band 80-84 581,553 12,026 569,527 97.9 604,443
85-89 351,260 7,714 343,546 97.8 365,421
90+ 177,121 4,312 172,809 97.6 186,459
Ethnicity (broad categories) Black 8,918 1,197 7,721 86.6 11,529
Mixed 2,975 231 2,744 92.2 3,549
Other 6,069 392 5,677 93.5 7,266
South Asian 26,845 3,283 23,562 87.8 30,450
Unknown 37,863 1,218 36,645 96.8 45,227
White 1,027,264 17,738 1,009,526 98.3 1,058,309
Ethnicity (detailed categories) African 1,589 308 1,281 80.6 2,261
Bangladeshi or British Bangladeshi 1,176 252 924 78.6 1,386
Caribbean 6,118 735 5,383 88.0 7,651
Chinese 1,533 70 1,463 95.4 1,890
Other 4,529 322 4,207 92.9 5,376
Other Asian 4,207 406 3,801 90.3 4,935
British or Mixed British 975,373 16,093 959,280 98.4 1,002,106
Indian or British Indian 14,728 812 13,916 94.5 16,107
Irish 9,590 287 9,303 97.0 10,143
Other Black 1,211 154 1,057 87.3 1,624
Other White 42,329 1,365 40,964 96.8 46,088
Other mixed 1,106 70 1,036 93.7 1,260
Pakistani or British Pakistani 6,734 1,813 4,921 73.1 8,015
Unknown 37,842 1,211 36,631 96.8 45,199
White + Asian 532 21 511 96.1 602
White + Black African 308 28 280 90.9 434
White + Black Caribbean 1,022 105 917 89.7 1,246
Index of Multiple Deprivation (quintiles) 1 Most deprived 135,023 6,342 128,681 95.3 144,438
2 181,951 5,096 176,855 97.2 191,359
3 250,950 4,823 246,127 98.1 260,708
4 260,470 4,060 256,410 98.4 269,444
5 Least deprived 260,729 3,220 257,509 98.8 268,121
Unknown 20,811 518 20,293 97.5 22,253
BMI 30+ 200,809 4,228 196,581 97.9 206,234
under 30 909,125 19,824 889,301 97.8 950,089
Housebound no 1,003,723 20,636 983,087 97.9 1,045,387
yes 106,218 3,423 102,795 96.8 110,943
Chronic cardiac disease no 775,208 16,870 758,338 97.8 811,930
yes 334,726 7,182 327,544 97.9 344,393
Current COPD no 992,523 21,294 971,229 97.9 1,035,615
yes 117,411 2,758 114,653 97.7 120,708
DMARDs no 1,073,709 23,408 1,050,301 97.8 1,119,307
yes 36,225 644 35,581 98.2 37,016
Dementia no 1,026,522 21,119 1,005,403 97.9 1,069,187
yes 83,419 2,940 80,479 96.5 87,136
Psychosis, schizophrenia, or bipolar no 1,102,080 23,660 1,078,420 97.9 1,147,860
yes 7,861 399 7,462 94.9 8,470
Learning disability no 1,109,430 24,024 1,085,406 97.8 1,155,784
yes 504 28 476 94.4 539
SSRI (last 12 months) no 1,065,379 23,114 1,042,265 97.8 1,110,697
yes 44,555 938 43,617 97.9 45,633
Chemo or radiotherapy no 1,070,118 23,415 1,046,703 97.8 1,115,618
yes 39,816 637 39,179 98.4 40,705
Cancer (lung) no 1,101,919 23,842 1,078,077 97.8 1,148,112
yes 8,015 210 7,805 97.4 8,218
Cancer (excluding lung/haem) no 902,293 20,769 881,524 97.7 943,530
yes 207,641 3,283 204,358 98.4 212,800
Cancer (haematological) no 1,088,745 23,730 1,065,015 97.8 1,134,616
yes 21,189 322 20,867 98.5 21,707
Chronic kidney disease no 769,566 16,765 752,801 97.8 806,092
yes 340,368 7,287 333,081 97.9 350,238
Immune-mediated inflammatory disease no 1,010,044 22,141 987,903 97.8 1,053,675
yes 99,897 1,918 97,979 98.1 102,648

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among 80+ Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 2,053,779 55,608 1,998,171 97.3 2,157,470
Sex F 1,078,147 30,996 1,047,151 97.1 1,131,746
M 975,625 24,619 951,006 97.5 1,025,710
Age band 70-74 1,101,961 35,784 1,066,177 96.8 1,165,080
75-79 951,811 19,831 931,980 97.9 992,376
Ethnicity (broad categories) Black 11,739 1,764 9,975 85.0 15,757
Mixed 5,950 518 5,432 91.3 7,154
Other 14,371 1,141 13,230 92.1 17,787
South Asian 54,824 6,356 48,468 88.4 62,594
Unknown 90,713 3,759 86,954 95.9 105,777
White 1,876,175 42,077 1,834,098 97.8 1,948,387
Ethnicity (detailed categories) African 4,172 728 3,444 82.6 5,901
Bangladeshi or British Bangladeshi 1,813 371 1,442 79.5 2,156
Caribbean 5,215 714 4,501 86.3 6,818
Chinese 3,913 203 3,710 94.8 4,935
Other 10,451 931 9,520 91.1 12,852
Other Asian 10,857 987 9,870 90.9 12,663
British or Mixed British 1,782,186 37,842 1,744,344 97.9 1,841,910
Indian or British Indian 30,737 1,974 28,763 93.6 34,097
Irish 14,728 532 14,196 96.4 15,792
Other Black 2,352 322 2,030 86.3 3,031
Other White 79,247 3,717 75,530 95.3 90,671
Other mixed 2,464 189 2,275 92.3 2,898
Pakistani or British Pakistani 11,410 3,017 8,393 73.6 13,678
Unknown 90,734 3,759 86,975 95.9 105,791
White + Asian 1,344 84 1,260 93.8 1,526
White + Black African 931 119 812 87.2 1,197
White + Black Caribbean 1,218 126 1,092 89.7 1,533
Index of Multiple Deprivation (quintiles) 1 Most deprived 260,533 14,161 246,372 94.6 281,309
2 342,678 11,858 330,820 96.5 363,776
3 460,964 11,270 449,694 97.6 483,217
4 477,029 9,478 467,551 98.0 497,175
5 Least deprived 471,240 7,448 463,792 98.4 487,256
Unknown 41,335 1,407 39,928 96.6 44,730
BMI 30+ 521,976 13,706 508,270 97.4 539,553
under 30 1,531,796 41,909 1,489,887 97.3 1,617,903
Housebound no 2,017,225 53,746 1,963,479 97.3 2,118,844
yes 36,540 1,855 34,685 94.9 38,612
Chronic cardiac disease no 1,683,402 44,989 1,638,413 97.3 1,773,744
yes 370,370 10,619 359,751 97.1 383,712
Current COPD no 1,861,013 49,315 1,811,698 97.4 1,957,949
yes 192,759 6,300 186,459 96.7 199,514
DMARDs no 1,979,082 53,949 1,925,133 97.3 2,080,883
yes 74,683 1,652 73,031 97.8 76,573
Dementia no 2,013,298 53,858 1,959,440 97.3 2,115,162
yes 40,474 1,750 38,724 95.7 42,294
Psychosis, schizophrenia, or bipolar no 2,034,424 54,418 1,980,006 97.3 2,136,239
yes 19,341 1,190 18,151 93.8 21,217
Learning disability no 2,050,832 55,391 1,995,441 97.3 2,154,327
yes 2,940 224 2,716 92.4 3,129
SSRI (last 12 months) no 1,946,182 52,626 1,893,556 97.3 2,046,835
yes 107,590 2,982 104,608 97.2 110,628
Chemo or radiotherapy no 1,981,588 54,124 1,927,464 97.3 2,083,375
yes 72,184 1,491 70,693 97.9 74,081
Cancer (lung) no 2,040,339 55,209 1,985,130 97.3 2,143,596
yes 13,433 399 13,034 97.0 13,860
Cancer (excluding lung/haem) no 1,757,084 49,623 1,707,461 97.2 1,852,137
yes 296,688 5,985 290,703 98.0 305,319
Cancer (haematological) no 2,022,300 54,971 1,967,329 97.3 2,125,088
yes 31,472 644 30,828 98.0 32,375
Chronic kidney disease no 1,795,052 48,965 1,746,087 97.3 1,890,721
yes 258,720 6,643 252,077 97.4 266,742
Immune-mediated inflammatory disease no 1,857,716 50,848 1,806,868 97.3 1,954,918
yes 196,056 4,767 191,289 97.6 202,538

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among 70-79 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among care home population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 107,821 3,003 104,818 97.2 117,341
Sex F 74,998 1,876 73,122 97.5 81,270
M 32,823 1,127 31,696 96.6 36,071
Age band 65-69 5,908 385 5,523 93.5 6,566
70-74 8,505 448 8,057 94.7 9,408
75-79 13,720 476 13,244 96.5 15,085
80-84 18,704 518 18,186 97.2 20,398
85-89 25,221 567 24,654 97.8 27,384
90+ 35,763 609 35,154 98.3 38,493
Ethnicity (broad categories) Black 651 56 595 91.4 812
Mixed 329 14 315 95.7 371
Other 525 28 497 94.7 581
South Asian 987 77 910 92.2 1,127
Unknown 1,806 35 1,771 98.1 2,114
White 103,523 2,793 100,730 97.3 112,336
Dementia no 49,686 1,659 48,027 96.7 54,803
yes 58,135 1,344 56,791 97.7 62,538

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Third Doses Overdue Among Care Home Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 715,183 99,008 616,175 86.2 799,470
newly shielded since feb 15 no 425,866 42,756 383,110 90.0 465,108
yes 289,317 56,259 233,058 80.6 334,362
Sex F 404,362 60,305 344,057 85.1 453,026
M 310,807 38,703 272,104 87.5 346,430
Age band 16-29 47,677 12,978 34,699 72.8 60,305
30-39 100,611 23,982 76,629 76.2 121,254
40-49 141,351 24,899 116,452 82.4 160,580
50-59 204,701 22,680 182,021 88.9 223,146
60-69 220,836 14,476 206,360 93.4 234,178
Ethnicity (broad categories) Black 33,467 9,674 23,793 71.1 44,282
Mixed 11,109 2,492 8,617 77.6 14,203
Other 14,490 3,199 11,291 77.9 17,787
South Asian 93,604 25,214 68,390 73.1 106,400
Unknown 17,773 2,436 15,337 86.3 20,552
White 544,726 56,000 488,726 89.7 596,225
Index of Multiple Deprivation (quintiles) 1 Most deprived 199,297 41,118 158,179 79.4 232,701
2 159,292 24,206 135,086 84.8 179,459
3 138,460 15,386 123,074 88.9 152,439
4 110,565 9,597 100,968 91.3 119,525
5 Least deprived 87,605 5,789 81,816 93.4 92,841
Unknown 19,950 2,919 17,031 85.4 22,491
Learning disability no 690,543 96,607 593,936 86.0 772,625
yes 24,626 2,408 22,218 90.2 26,831
Chronic kidney disease no 664,160 94,500 569,660 85.8 744,520
yes 51,009 4,508 46,501 91.2 54,929
Immune-mediated inflammatory disease no 585,200 86,219 498,981 85.3 659,449
yes 129,969 12,789 117,180 90.2 140,007

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among Shielding (Aged 16-69) Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,038,940 48,566 990,374 95.3 1,125,215
Sex F 532,364 25,277 507,087 95.3 573,958
M 506,569 23,289 483,280 95.4 551,243
Ethnicity (broad categories) Black 9,485 1,806 7,679 81.0 13,083
Mixed 4,571 518 4,053 88.7 5,691
Other 10,584 1,218 9,366 88.5 13,825
South Asian 41,356 6,293 35,063 84.8 48,027
Unknown 62,244 3,822 58,422 93.9 76,678
White 910,693 34,909 875,784 96.2 967,911
Ethnicity (detailed categories) African 3,647 763 2,884 79.1 5,110
Bangladeshi or British Bangladeshi 1,750 364 1,386 79.2 2,030
Caribbean 3,696 693 3,003 81.2 5,180
Chinese 3,479 280 3,199 92.0 4,550
Other 7,119 938 6,181 86.8 9,282
Other Asian 7,861 861 7,000 89.0 9,317
British or Mixed British 859,775 30,422 829,353 96.5 903,539
Indian or British Indian 22,092 2,023 20,069 90.8 24,955
Irish 6,286 371 5,915 94.1 6,979
Other Black 2,128 329 1,799 84.5 2,786
Other White 44,611 4,130 40,481 90.7 57,372
Other mixed 1,827 182 1,645 90.0 2,254
Pakistani or British Pakistani 9,653 3,045 6,608 68.5 11,725
Unknown 62,251 3,822 58,429 93.9 76,678
White + Asian 994 77 917 92.3 1,141
White + Black African 770 98 672 87.3 1,022
White + Black Caribbean 987 161 826 83.7 1,274
Index of Multiple Deprivation (quintiles) 1 Most deprived 142,093 12,852 129,241 91.0 161,252
2 180,292 10,731 169,561 94.0 198,625
3 231,343 9,639 221,704 95.8 249,606
4 234,850 7,861 226,989 96.7 250,446
5 Least deprived 227,199 6,174 221,025 97.3 239,372
Unknown 23,163 1,316 21,847 94.3 25,907
BMI 30+ 270,375 11,564 258,811 95.7 284,522
under 30 768,558 37,002 731,556 95.2 840,679
Housebound no 1,034,460 48,160 986,300 95.3 1,120,245
yes 4,473 406 4,067 90.9 4,963
Chronic cardiac disease no 928,221 42,980 885,241 95.4 1,007,972
yes 110,719 5,593 105,126 94.9 117,236
Current COPD no 998,739 46,165 952,574 95.4 1,082,340
yes 40,194 2,401 37,793 94.0 42,868
DMARDs no 1,018,269 47,768 970,501 95.3 1,103,620
yes 20,664 798 19,866 96.1 21,588
Dementia no 1,033,417 48,188 985,229 95.3 1,119,293
yes 5,523 385 5,138 93.0 5,915
Psychosis, schizophrenia, or bipolar no 1,028,146 47,579 980,567 95.4 1,112,888
yes 10,794 994 9,800 90.8 12,320
Learning disability no 1,036,483 48,335 988,148 95.3 1,122,548
yes 2,450 231 2,219 90.6 2,660
SSRI (last 12 months) no 975,863 45,535 930,328 95.3 1,059,205
yes 63,077 3,038 60,039 95.2 65,996
Chemo or radiotherapy no 1,018,486 47,866 970,620 95.3 1,103,872
yes 20,454 707 19,747 96.5 21,336
Cancer (lung) no 1,036,665 48,440 988,225 95.3 1,122,807
yes 2,268 126 2,142 94.4 2,401
Cancer (excluding lung/haem) no 949,438 45,332 904,106 95.2 1,031,513
yes 89,495 3,234 86,261 96.4 93,695
Cancer (haematological) no 1,034,887 48,398 986,489 95.3 1,120,917
yes 4,046 168 3,878 95.8 4,291
Chronic kidney disease no 991,298 46,473 944,825 95.3 1,075,088
yes 47,635 2,093 45,542 95.6 50,120
Immune-mediated inflammatory disease no 956,578 45,122 911,456 95.3 1,038,408
yes 82,355 3,444 78,911 95.8 86,800

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among 65-69 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among Learning Disabilities (aged 16-64) population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 73,465 12,369 61,096 83.2 87,794
Sex F 28,385 4,291 24,094 84.9 33,082
M 45,080 8,085 36,995 82.1 54,712
Age band 16-17 2,702 1,309 1,393 51.6 4,746
18-29 25,249 5,537 19,712 78.1 31,577
30-34 9,821 1,659 8,162 83.1 11,760
35-39 7,322 1,050 6,272 85.7 8,519
40-44 5,852 686 5,166 88.3 6,629
45-49 5,362 567 4,795 89.4 5,922
50-54 6,083 588 5,495 90.3 6,622
55-59 6,167 511 5,656 91.7 6,713
60-64 4,893 448 4,445 90.8 5,299
Ethnicity (broad categories) Black 917 294 623 67.9 1,554
Mixed 875 238 637 72.8 1,274
Other 609 161 448 73.6 847
South Asian 3,962 1,484 2,478 62.5 5,292
Unknown 4,270 735 3,535 82.8 5,159
White 62,825 9,450 53,375 85.0 73,668

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those who are shielding.

Third Doses Overdue Among People With Learning Disabilities (Aged 16-64)

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 60-64 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,232,602 84,259 1,148,343 93.2 1,361,052
Sex F 620,921 41,594 579,327 93.3 678,111
M 611,681 42,672 569,009 93.0 682,934
Ethnicity (broad categories) Black 16,177 3,983 12,194 75.4 23,023
Mixed 7,196 1,022 6,174 85.8 9,261
Other 14,273 2,051 12,222 85.6 19,152
South Asian 48,916 8,645 40,271 82.3 57,190
Unknown 84,784 6,755 78,029 92.0 106,330
White 1,061,249 61,796 999,453 94.2 1,146,089
Ethnicity (detailed categories) African 6,363 1,645 4,718 74.1 8,785
Bangladeshi or British Bangladeshi 2,275 441 1,834 80.6 2,639
Caribbean 5,817 1,505 4,312 74.1 8,778
Chinese 4,389 364 4,025 91.7 5,733
Other 9,877 1,687 8,190 82.9 13,419
Other Asian 10,801 1,463 9,338 86.5 12,852
British or Mixed British 995,988 53,263 942,725 94.7 1,059,611
Indian or British Indian 24,815 2,940 21,875 88.2 28,385
Irish 6,384 476 5,908 92.5 7,224
Other Black 4,004 840 3,164 79.0 5,467
Other White 58,884 8,057 50,827 86.3 79,261
Other mixed 2,695 336 2,359 87.5 3,493
Pakistani or British Pakistani 11,032 3,808 7,224 65.5 13,321
Unknown 84,777 6,762 78,015 92.0 106,316
White + Asian 1,484 147 1,337 90.1 1,729
White + Black African 1,295 224 1,071 82.7 1,694
White + Black Caribbean 1,715 308 1,407 82.0 2,338
Index of Multiple Deprivation (quintiles) 1 Most deprived 179,802 22,820 156,982 87.3 210,812
2 217,882 18,781 199,101 91.4 245,651
3 270,536 16,730 253,806 93.8 297,038
4 273,945 13,748 260,197 95.0 296,415
5 Least deprived 262,486 10,101 252,385 96.2 279,377
Unknown 27,951 2,079 25,872 92.6 31,738
BMI 30+ 313,831 19,425 294,406 93.8 334,138
under 30 918,771 64,841 853,930 92.9 1,026,907
Chronic cardiac disease no 1,139,908 77,462 1,062,446 93.2 1,261,344
yes 92,687 6,797 85,890 92.7 99,701
Current COPD no 1,198,092 81,123 1,116,969 93.2 1,323,504
yes 34,503 3,136 31,367 90.9 37,541
DMARDs no 1,210,832 83,083 1,127,749 93.1 1,338,071
yes 21,763 1,176 20,587 94.6 22,974
Dementia no 1,228,997 83,958 1,145,039 93.2 1,357,139
yes 3,598 301 3,297 91.6 3,906
Psychosis, schizophrenia, or bipolar no 1,218,805 82,642 1,136,163 93.2 1,344,826
yes 13,790 1,610 12,180 88.3 16,219
SSRI (last 12 months) no 1,147,013 78,309 1,068,704 93.2 1,270,346
yes 85,582 5,950 79,632 93.0 90,699
Chemo or radiotherapy no 1,213,786 83,223 1,130,563 93.1 1,341,214
yes 18,816 1,043 17,773 94.5 19,831
Cancer (lung) no 1,231,118 84,119 1,146,999 93.2 1,359,414
yes 1,484 140 1,344 90.6 1,631
Cancer (excluding lung/haem) no 1,158,010 80,269 1,077,741 93.1 1,282,050
yes 74,585 3,990 70,595 94.7 78,995
Cancer (haematological) no 1,228,913 84,042 1,144,871 93.2 1,357,104
yes 3,682 217 3,465 94.1 3,941
Chronic kidney disease no 1,201,753 82,292 1,119,461 93.2 1,328,117
yes 30,842 1,960 28,882 93.6 32,928
Immune-mediated inflammatory disease no 1,141,714 78,645 1,063,069 93.1 1,263,857
yes 90,881 5,607 85,274 93.8 97,188

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among 60-64 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 55-59 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,387,155 128,156 1,258,999 90.8 1,568,266
Sex F 696,339 61,019 635,320 91.2 771,442
M 690,802 67,130 623,672 90.3 796,817
Ethnicity (broad categories) Black 23,989 6,755 17,234 71.8 34,874
Mixed 10,612 1,883 8,729 82.3 13,853
Other 18,830 3,164 15,666 83.2 25,809
South Asian 56,420 11,837 44,583 79.0 66,710
Unknown 102,200 10,731 91,469 89.5 133,378
White 1,175,097 93,786 1,081,311 92.0 1,293,635
Ethnicity (detailed categories) African 10,815 3,171 7,644 70.7 15,022
Bangladeshi or British Bangladeshi 2,926 651 2,275 77.8 3,388
Caribbean 6,958 1,946 5,012 72.0 11,074
Chinese 5,628 581 5,047 89.7 7,392
Other 13,188 2,576 10,612 80.5 18,403
Other Asian 13,874 2,261 11,613 83.7 16,821
British or Mixed British 1,095,437 81,270 1,014,167 92.6 1,184,078
Indian or British Indian 26,733 3,871 22,862 85.5 30,730
Irish 7,371 749 6,622 89.8 8,666
Other Black 6,216 1,638 4,578 73.6 8,778
Other White 72,303 11,774 60,529 83.7 100,912
Other mixed 3,808 644 3,164 83.1 5,005
Pakistani or British Pakistani 12,887 5,061 7,826 60.7 15,764
Unknown 102,200 10,717 91,483 89.5 133,378
White + Asian 2,198 245 1,953 88.9 2,597
White + Black African 2,023 448 1,575 77.9 2,688
White + Black Caribbean 2,576 553 2,023 78.5 3,556
Index of Multiple Deprivation (quintiles) 1 Most deprived 209,496 34,279 175,217 83.6 254,800
2 247,114 28,994 218,120 88.3 286,832
3 301,441 25,795 275,646 91.4 338,611
4 304,430 20,755 283,675 93.2 335,496
5 Least deprived 293,629 15,442 278,187 94.7 316,785
Unknown 31,031 2,891 28,140 90.7 35,728
BMI 30+ 341,208 28,462 312,746 91.7 368,158
under 30 1,045,933 99,687 946,246 90.5 1,200,094
Chronic cardiac disease no 1,318,527 121,366 1,197,161 90.8 1,492,960
yes 68,614 6,783 61,831 90.1 75,292
Current COPD no 1,361,164 124,908 1,236,256 90.8 1,539,125
yes 25,977 3,241 22,736 87.5 29,127
DMARDs no 1,365,770 126,637 1,239,133 90.7 1,545,369
yes 21,371 1,512 19,859 92.9 22,883
Psychosis, schizophrenia, or bipolar no 1,370,866 125,811 1,245,055 90.8 1,548,407
yes 16,282 2,352 13,930 85.6 19,845
SSRI (last 12 months) no 1,281,553 118,853 1,162,700 90.7 1,455,097
yes 105,588 9,296 96,292 91.2 113,155
Chronic kidney disease no 1,366,911 126,511 1,240,400 90.7 1,546,279
yes 20,230 1,645 18,585 91.9 21,973
Immune-mediated inflammatory disease no 1,288,469 119,777 1,168,692 90.7 1,460,907
yes 98,672 8,372 90,300 91.5 107,345

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among 55-59 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 50-54 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 1,361,983 168,021 1,193,962 87.7 1,589,448
Sex F 687,099 77,861 609,238 88.7 775,530
M 674,870 90,160 584,710 86.6 813,897
Ethnicity (broad categories) Black 27,188 8,722 18,466 67.9 40,117
Mixed 12,208 2,562 9,646 79.0 16,646
Other 23,996 4,865 19,131 79.7 33,999
South Asian 79,898 20,335 59,563 74.5 96,733
Unknown 104,776 13,615 91,161 87.0 142,366
White 1,113,910 117,929 995,981 89.4 1,259,566
Ethnicity (detailed categories) African 15,330 5,117 10,213 66.6 21,651
Bangladeshi or British Bangladeshi 4,949 1,211 3,738 75.5 5,733
Caribbean 5,306 1,582 3,724 70.2 8,988
Chinese 6,720 861 5,859 87.2 9,093
Other 17,283 4,004 13,279 76.8 24,913
Other Asian 19,740 3,773 15,967 80.9 24,311
British or Mixed British 1,020,376 99,001 921,375 90.3 1,122,471
Indian or British Indian 33,537 5,978 27,559 82.2 39,459
Irish 6,881 854 6,027 87.6 8,351
Other Black 6,545 2,016 4,529 69.2 9,478
Other White 86,646 18,067 68,579 79.1 128,744
Other mixed 4,438 896 3,542 79.8 6,216
Pakistani or British Pakistani 21,672 9,380 12,292 56.7 27,230
Unknown 104,797 13,622 91,175 87.0 142,387
White + Asian 2,660 392 2,268 85.3 3,255
White + Black African 2,632 707 1,925 73.1 3,619
White + Black Caribbean 2,471 574 1,897 76.8 3,535
Index of Multiple Deprivation (quintiles) 1 Most deprived 217,616 46,550 171,066 78.6 278,593
2 246,813 38,402 208,411 84.4 298,046
3 288,078 32,683 255,395 88.7 333,403
4 291,711 26,502 265,209 90.9 328,832
5 Least deprived 285,425 20,027 265,398 93.0 312,627
Unknown 32,333 3,864 28,469 88.0 37,926
BMI 30+ 321,216 35,469 285,747 89.0 352,051
under 30 1,040,760 132,559 908,201 87.3 1,237,383
Chronic cardiac disease no 1,318,842 162,281 1,156,561 87.7 1,540,686
yes 43,134 5,747 37,387 86.7 48,741
Current COPD no 1,345,484 165,319 1,180,165 87.7 1,570,352
yes 16,485 2,702 13,783 83.6 19,075
DMARDs no 1,343,986 166,439 1,177,547 87.6 1,569,911
yes 17,990 1,589 16,401 91.2 19,516
Psychosis, schizophrenia, or bipolar no 1,345,666 165,228 1,180,438 87.7 1,568,763
yes 16,310 2,793 13,517 82.9 20,671
SSRI (last 12 months) no 1,253,609 156,093 1,097,516 87.5 1,471,862
yes 108,367 11,935 96,432 89.0 117,572
Chronic kidney disease no 1,350,993 166,838 1,184,155 87.7 1,577,275
yes 10,976 1,176 9,800 89.3 12,159
Immune-mediated inflammatory disease no 1,270,227 157,815 1,112,412 87.6 1,487,668
yes 91,749 10,213 81,536 88.9 101,766

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among 50-54 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 40-49 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 2,337,818 466,277 1,871,541 80.1 3,024,098
Sex F 1,189,475 215,726 973,749 81.9 1,445,206
M 1,148,308 250,544 897,764 78.2 1,578,836
Ethnicity (broad categories) Black 60,340 25,403 34,937 57.9 98,042
Mixed 30,289 8,680 21,609 71.3 45,906
Other 64,015 17,262 46,753 73.0 101,185
South Asian 216,664 70,448 146,216 67.5 290,255
Unknown 167,706 35,056 132,650 79.1 263,249
White 1,798,762 309,414 1,489,348 82.8 2,225,398
Ethnicity (detailed categories) African 40,474 17,325 23,149 57.2 62,230
Bangladeshi or British Bangladeshi 16,205 5,369 10,836 66.9 20,377
Caribbean 7,049 2,905 4,144 58.8 14,749
Chinese 17,283 2,646 14,637 84.7 25,949
Other 46,732 14,623 32,109 68.7 75,236
Other Asian 50,099 13,454 36,645 73.1 68,502
British or Mixed British 1,564,521 240,065 1,324,456 84.7 1,820,847
Indian or British Indian 91,084 20,741 70,343 77.2 120,582
Irish 11,130 1,883 9,247 83.1 15,316
Other Black 12,824 5,180 7,644 59.6 21,063
Other White 223,083 67,473 155,610 69.8 389,207
Other mixed 11,900 3,199 8,701 73.1 18,501
Pakistani or British Pakistani 59,262 30,877 28,385 47.9 80,780
Unknown 167,748 35,056 132,692 79.1 263,291
White + Asian 6,699 1,526 5,173 77.2 8,995
White + Black African 7,049 2,485 4,564 64.7 10,570
White + Black Caribbean 4,648 1,477 3,171 68.2 7,840
Index of Multiple Deprivation (quintiles) 1 Most deprived 400,078 128,359 271,719 67.9 592,557
2 434,805 105,455 329,350 75.7 594,314
3 483,084 90,734 392,350 81.2 619,794
4 478,849 72,758 406,091 84.8 584,479
5 Least deprived 469,175 55,657 413,518 88.1 543,669
Unknown 71,792 13,314 58,478 81.5 89,229
BMI 30+ 446,152 80,927 365,225 81.9 517,314
under 30 1,891,624 385,343 1,506,281 79.6 2,506,721
Chronic cardiac disease no 2,304,162 459,949 1,844,213 80.0 2,983,624
yes 33,614 6,321 27,293 81.2 40,418
Current COPD no 2,325,477 463,456 1,862,021 80.1 3,008,600
yes 12,299 2,814 9,485 77.1 15,442
DMARDs no 2,313,906 462,903 1,851,003 80.0 2,996,910
yes 23,877 3,374 20,503 85.9 27,132
Psychosis, schizophrenia, or bipolar no 2,309,615 459,921 1,849,694 80.1 2,985,941
yes 28,161 6,349 21,812 77.5 38,094
SSRI (last 12 months) no 2,175,222 438,200 1,737,022 79.9 2,838,052
yes 162,561 28,077 134,484 82.7 185,983
Chronic kidney disease no 2,328,340 464,751 1,863,589 80.0 3,013,087
yes 9,436 1,512 7,924 84.0 10,955
Immune-mediated inflammatory disease no 2,196,159 441,259 1,754,900 79.9 2,856,308
yes 141,617 25,004 116,613 82.3 167,734

Footnotes:

  • Patient counts rounded to the nearest 7.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.
  • Immune-mediated inflammatory disease is defined as the presence of a relevant diagnostic code.

Third Doses Overdue Among 40-49 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 30-39 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 2,298,863 707,469 1,591,394 69.2 3,443,097
Sex F 1,193,150 340,760 852,390 71.4 1,668,611
M 1,105,636 366,688 738,948 66.8 1,774,374
Ethnicity (broad categories) Black 49,987 27,615 22,372 44.8 104,587
Mixed 36,351 13,825 22,526 62.0 66,360
Other 66,528 23,821 42,707 64.2 129,584
South Asian 225,204 94,542 130,662 58.0 354,613
Unknown 173,768 57,386 116,382 67.0 303,093
White 1,746,955 490,266 1,256,689 71.9 2,484,748
Ethnicity (detailed categories) African 33,789 18,851 14,938 44.2 65,709
Bangladeshi or British Bangladeshi 15,757 7,105 8,652 54.9 23,142
Caribbean 5,796 3,066 2,730 47.1 16,177
Chinese 16,380 3,269 13,111 80.0 33,334
Other 50,155 20,552 29,603 59.0 96,236
Other Asian 50,309 18,389 31,920 63.4 81,704
British or Mixed British 1,501,444 390,901 1,110,543 74.0 1,949,010
Indian or British Indian 97,230 30,905 66,325 68.2 151,991
Irish 10,087 2,611 7,476 74.1 17,024
Other Black 10,388 5,684 4,704 45.3 22,701
Other White 235,417 96,747 138,670 58.9 518,728
Other mixed 14,728 5,285 9,443 64.1 26,936
Pakistani or British Pakistani 61,901 38,150 23,751 38.4 97,790
Unknown 173,782 57,372 116,410 67.0 303,093
White + Asian 8,351 2,597 5,754 68.9 12,894
White + Black African 6,349 2,933 3,416 53.8 11,578
White + Black Caribbean 6,916 3,017 3,899 56.4 14,945
Index of Multiple Deprivation (quintiles) 1 Most deprived 435,407 187,369 248,038 57.0 770,280
2 463,554 162,253 301,301 65.0 739,312
3 476,574 138,621 337,953 70.9 700,903
4 438,312 110,551 327,761 74.8 601,993
5 Least deprived 373,975 79,758 294,217 78.7 483,161
Unknown 110,957 28,882 82,075 74.0 147,336

Footnotes:

  • Patient counts rounded to the nearest 7.

Third Doses Overdue Among 30-39 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative third dose vaccination figures among 18-29 population

Please refer to footnotes below table for information.

Third Doses due at 22 Jun 2022 (n) Third doses overdue (n) Third doses given (n) Third doses given (% of due) Total population
Category Group
overall overall 2,197,734 872,746 1,324,988 60.3 3,502,282
Sex F 1,128,743 416,374 712,369 63.1 1,726,445
M 1,068,788 456,302 612,486 57.3 1,775,522
Ethnicity (broad categories) Black 42,462 28,728 13,734 32.3 110,152
Mixed 40,523 18,788 21,735 53.6 81,781
Other 60,690 27,468 33,222 54.7 149,583
South Asian 184,646 100,114 84,532 45.8 326,396
Unknown 305,879 119,371 186,508 61.0 491,505
White 1,563,331 578,214 985,117 63.0 2,342,550
Ethnicity (detailed categories) African 27,055 18,739 8,316 30.7 66,451
Bangladeshi or British Bangladeshi 15,078 8,827 6,251 41.5 25,340
Caribbean 5,320 3,304 2,016 37.9 16,702
Chinese 21,882 7,798 14,084 64.4 60,326
Other 38,808 19,670 19,138 49.3 89,250
Other Asian 40,355 19,495 20,860 51.7 74,074
British or Mixed British 1,413,713 506,674 907,039 64.2 1,970,598
Indian or British Indian 75,446 34,160 41,286 54.7 124,250
Irish 6,853 2,611 4,242 61.9 12,740
Other Black 10,094 6,685 3,409 33.8 26,992
Other White 142,716 68,915 73,801 51.7 359,163
Other mixed 14,931 6,888 8,043 53.9 30,597
Pakistani or British Pakistani 53,767 37,632 16,135 30.0 102,746
Unknown 305,942 119,378 186,564 61.0 491,568
White + Asian 10,745 3,983 6,762 62.9 17,892
White + Black African 6,286 3,591 2,695 42.9 13,636
White + Black Caribbean 8,540 4,312 4,228 49.5 19,635
Index of Multiple Deprivation (quintiles) 1 Most deprived 404,460 211,379 193,081 47.7 792,253
2 439,754 193,585 246,169 56.0 746,655
3 459,417 174,251 285,166 62.1 706,986
4 424,970 145,229 279,741 65.8 611,772
5 Least deprived 385,595 117,887 267,708 69.4 518,385
Unknown 83,335 30,345 52,990 63.6 125,923

Footnotes:

  • Patient counts rounded to the nearest 7.

Third Doses Overdue Among 18-29 Population

Third doses which have not been given at least 14 weeks since the second dose

Error bars indicate possible error caused by rounding

Summary

Third Doses due at 22 Jun 2022 (n) Third doses given (% of due) Third doses given (n) Third doses overdue (n) Total population
80+ 1,109,941 97.8 1,085,882 24,059 1,156,330
70-79 2,053,779 97.3 1,998,171 55,608 2,157,470
care home 107,821 97.2 104,818 3,003 117,341
shielding (aged 16-69) 715,183 86.2 616,175 99,008 799,470
65-69 1,038,940 95.3 990,374 48,566 1,125,215
LD (aged 16-64) 73,465 83.2 61,096 12,369 87,794
60-64 1,232,602 93.2 1,148,343 84,259 1,361,052
55-59 1,387,155 90.8 1,258,999 128,156 1,568,266
50-54 1,361,983 87.7 1,193,962 168,021 1,589,448
40-49 2,337,818 80.1 1,871,541 466,277 3,024,098
30-39 2,298,863 69.2 1,591,394 707,469 3,443,097
18-29 2,197,734 60.3 1,324,988 872,746 3,502,282